Cryobeauty Pharma

Key People

• Denis Marin - Co-Founder, President, Director & Chief Executive Officer
• Jean-Christophe Anton - Co-Founder & Director, Operations
• Serge Durand - Co-Founder & Director

Assessment

Team

Aspect: First-time 10+ yrs
Summary: The founding team comprises experienced professionals with over a decade in their respective fields.

The leadership team, including CEO Denis Marin, brings substantial experience, enhancing the company's strategic direction and operational execution.

Clinical Need

Aspect: Good
Summary: The product addresses a common dermatological concern with an innovative solution.

Cryobeauty Mains offers a novel, painless treatment for brown spots, meeting a significant demand in aesthetic dermatology.

Competition

Aspect: Somewhat crowded
Summary: The market has several players offering similar aesthetic treatments.

While Cryobeauty Pharma's technology is innovative, it competes in a market with multiple established aesthetic device manufacturers.

Technical Challenge

Aspect: Predictable
Summary: The technology is well-understood with manageable development risks.

The cryotherapy technology employed is established, reducing technical uncertainties in product development.

Patent

Aspect: Strong
Summary: The company holds multiple patents, indicating a solid intellectual property position.

With 28 patents, including 20 granted and 7 pending, Cryobeauty Pharma demonstrates a strong commitment to protecting its innovations.

Financing

Aspect: Medium
Summary: The company has secured significant funding but may require additional capital for expansion.

Having raised $7.21 million, including a $5.5 million round in April 2022, the company is well-funded but may need further investment for scaling operations.

Regulatory

Aspect: 510k/PMA
Summary: The product has obtained CE marking, facilitating European market entry.

Achieving CE marking in early 2018 allows Cryobeauty Mains to be marketed in Europe; however, FDA approval would be necessary for U.S. market entry.

Opportunity Rollup

Odds of Success

3.25

Peak Market Share

4.6

Segment CAGR

6.3%

Market Segment

Aesthetic Devices

Market Sub Segment

Cryotherapy Devices

Key Takeaway

Cryobeauty Pharma's innovative cryotherapy device addresses a significant market need, but strategic efforts are required to navigate competition and regulatory challenges for successful global expansion.